Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

The first utility-oriented, agnostic software platform for quantum-centric drug discovery

Project description

Platform-agnostic quantum software for drug research

While quantum hardware is advancing commercially, effective quantum software for real business problems is still lacking. This complexity can hinder non-coding experts from extracting valuable insights. Kvantify has developed Kvaser, an explainable, platform-agnostic quantum software tool designed for end-user operation. The EIC-funded KvasirAccelerator project will create advanced algorithms for quantum chemistry and machine learning to tackle real-life challenges in drug research and development that go beyond the capabilities of classical methods. Kvaser will enable R&D scientists to perform molecular and biochemical simulations on cutting-edge hardware with exceptional speed and accuracy, facilitating precise quantum chemistry calculations and accelerating drug discovery.

Objective

Humanity is exploring the limits of computing to solve the world’s biggest challenges with unprecedented speed and precision. While quantum hardware is being matured into a commercial technology, there is still no quantum software capable of addressing real business problems. Furthermore, quantum computing will inevitably exacerbate the complexity of current computational workflows for non-coding experts to extract knowledge. At Kvantify, we are developing Kvaser, the first platform-agnostic, explainable, customer-centric quantum software tool, to be operated by the end-user. With EIC funding, we will develop advanced algorithms for quantum chemistry and machine learning that will solve real-life drug R&D problems beyond the scope of classical resources. Kvaser will empower R&D scientists to run molecular and biochemical simulations on modern hardware with unmatched speed and accuracy, enabling high precision quantum chemistry calculations for efficient and accelerated drug discovery.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2023-ACCELERATOR-01

See all projects funded under this call

Coordinator

KVANTIFY APS
Net EU contribution
€ 2 499 999,00
Address
ROSENVAENGETS ALLE 25, st.
2100 KOBENHAVN O
Denmark
SME
Yes
Region
Danmark Hovedstaden Byen København
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 4 497 453,75